Ejemplo: Heart Attack

Buscar ensayos clínicos para: Fludarabine

Total 1564 resultados

NCT02514083

Activo, no reclutando

A Phase II Study Using Ibrutinib and Short-Course Fludarabine in Treatment-Naive CLL

Condiciones: Chronic Lymphocytic Leukemia; Small Lymphocytic Lymphoma
NCT04425655

Aún no reclutando

Fludarabine in Combination With Daunorubicin and Cytarabine Liposome in Newly-diagnosed Acute Myeloid Leukemia.

Condiciones: Acute Myeloid Leukemia, Adult; AML; AML, Adult
NCT01472055

Estado desconocido

Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation

Condiciones: Acute Leukemia; Chronic Leukemia; Severe Aplastic Anemia
NCT02926586

Estado desconocido

Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML

Condiciones: Acute Myeloid Leukemia; Core-Binding Factor
NCT03754933

Reclutamiento

Safety and Efficacy of Repeat Administration of Ad/PNP and Fludarabine Phosphate in Patients With Local Head/Neck Cancer

Condiciones: Recurrent Head and Neck Cancer
NCT00278265

Terminado

Methotrexate Followed by Fludarabine in Patients With T-Cell Large Granular Lymphocytic Leukemia

Condiciones: T-Cell Large Granular Lymphocytic Leukemia
NCT02024308

Estado desconocido

AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy

Condiciones: Acute Myeloid Leukemia; AML1-ETO Fusion Protein Expression
NCT00502905

Completado

Busulfan and Fludarabine in Patients With AML and MDS

Condiciones: Leukemia
NCT03696537

Activo, no reclutando

IMRT-TMI With Fludarabine as Myeloablative Conditioning for Allogeneic HSCT

Condiciones: Acute Myeloid Leukemia; Chronic Myeloid Leukemia; Acute Lymphocytic Leukemia; Myelodysplastic Syndromes
NCT01019317

Completado

Fludarabine and Cytarabine in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS)

Condiciones: Leukemia; AML; MDS; CML
NCT01310179

Completado

Safety Study of Adenovirus/PNP Coupled With Fludarabine Phosphate to Treat Solid Tumors

Condiciones: Head and Neck Cancer
NCT00572897

Completado

Study of Fludarabine Based Conditioning for Allogeneic Stem Cell Transplantation for Myelofibrosis

Condiciones: Myelofibrosis
NCT00506857

Completado

Phase I/II Trial of Fludarabine Plus Busulfan and Allogeneic Progenitor Cell Support

Condiciones: Hematologic Malignancies
NCT03832127

Aún no reclutando

Evaluation of PET 18F-Fludarabine for the Initial Assessment and End-treatment of Symptomatic Multiple Myeloma Patients

Condiciones: Myeloma
NCT02128945

Completado

Dosimetry and Biodistribution of [18F]-Fludarabine in Lymphoid Malignancies

Condiciones: Untreated B-Chronic Lymphocytic Leukemia or Diffuse Large B Cells Lymphoma Patients
NCT00208975

Terminado

Phase II Study of Fludarabine and Mitoxantrone, Followed by GM-CSF(Granulocyte-macrophage Colony-stimulating Factor) and Rituximab

Condiciones: Lymphoma
NCT00625430

Estado desconocido

A Phase I Gene Therapy Study of FP253/Fludarabine for Prostate Cancer

Condiciones: Prostate Cancer
NCT00815568

Estado desconocido

Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI)

Condiciones: AML; MDS; ALL; CML; Lymphoma
NCT00004246

Completado

Radiation Therapy Plus Fludarabine in Treating Patients With Locally Advanced Cancer of the Mouth, Pharynx, or Larynx

Condiciones: Head and Neck Cancer
NCT00206726

Completado

Alemtuzumab/Fludarabine for Relapsed/Refractory B-cell Chronic Lymphocytic Leukemia (B-CLL)

Condiciones: Leukemia, Lymphocytic, Chronic, B-Cell
NCT01814475

Completado

Study to Compare Busulfan-fludarabine With Thiotepa-fludarabine Regimen in Allogeneic Transplantation for Myelofibrosis

Condiciones: Myelofibrosis
NCT00086580

Completado

Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients

Condiciones: B-Cell Chronic Lymphocytic Leukemia
NCT02718755

Retirado

Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies

Condiciones: Hematologic Malignancy
NCT03342196

Reclutamiento

Thiotepa Plus Fludarabine+ Melphalan as the Preparative Regime for Alternative Donor Transplantation

Condiciones: Leukemia
NCT01366612

Activo, no reclutando

PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation

Condiciones: Myeloid Malignancies; Acute Myelogenous Leukemia; Chronic Myelogenous Leukemia; Myeloproliferative Disorders; Myelodysplastic Syndrome